Logo image of XRX

XEROX HOLDINGS CORP (XRX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:XRX - US98421M1062 - Common Stock

2.69 USD
-0.04 (-1.47%)
Last: 11/26/2025, 11:58:44 AM
Fundamental Rating

3

Overall XRX gets a fundamental rating of 3 out of 10. We evaluated XRX against 35 industry peers in the Technology Hardware, Storage & Peripherals industry. XRX may be in some trouble as it scores bad on both profitability and health. XRX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

XRX had negative earnings in the past year.
In the past year XRX had a positive cash flow from operations.
In the past 5 years XRX reported 4 times negative net income.
XRX had a positive operating cash flow in each of the past 5 years.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B 1.5B

1.2 Ratios

XRX has a Return On Assets (-9.84%) which is in line with its industry peers.
The Return On Equity of XRX (-171.16%) is worse than 65.71% of its industry peers.
Industry RankSector Rank
ROA -9.84%
ROE -171.16%
ROIC N/A
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)N/A
ROIC(5y)N/A
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

XRX's Operating Margin has declined in the last couple of years.
The Gross Margin of XRX (27.61%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of XRX has declined.
The Profit Margin and Operating Margin are not available for XRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.61%
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

XRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XRX has more shares outstanding
XRX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, XRX has a worse debt to assets ratio.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.05, we must say that XRX is in the distress zone and has some risk of bankruptcy.
XRX's Altman-Z score of 1.05 is in line compared to the rest of the industry. XRX outperforms 45.71% of its industry peers.
The Debt to FCF ratio of XRX is 15.57, which is on the high side as it means it would take XRX, 15.57 years of fcf income to pay off all of its debts.
XRX's Debt to FCF ratio of 15.57 is in line compared to the rest of the industry. XRX outperforms 54.29% of its industry peers.
A Debt/Equity ratio of 7.00 is on the high side and indicates that XRX has dependencies on debt financing.
The Debt to Equity ratio of XRX (7.00) is worse than 74.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 7
Debt/FCF 15.57
Altman-Z 1.05
ROIC/WACCN/A
WACC5.6%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.10 indicates that XRX should not have too much problems paying its short term obligations.
XRX has a Current ratio of 1.10. This is in the lower half of the industry: XRX underperforms 62.86% of its industry peers.
XRX has a Quick Ratio of 1.10. This is a bad value and indicates that XRX is not financially healthy enough and could expect problems in meeting its short term obligations.
XRX has a Quick ratio (0.77) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.77
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.59%.
The earnings per share for XRX have been decreasing by -25.94% on average. This is quite bad
XRX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.67%.
XRX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.26% yearly.
EPS 1Y (TTM)-113.59%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-20%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%28.34%

3.2 Future

The Earnings Per Share is expected to grow by 14.60% on average over the next years. This is quite good.
XRX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.46% yearly.
EPS Next Y-77.7%
EPS Next 2Y22.66%
EPS Next 3Y14.6%
EPS Next 5YN/A
Revenue Next Year12.74%
Revenue Next 2Y10.51%
Revenue Next 3Y6.25%
Revenue Next 5Y-0.46%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XRX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 1.86, the valuation of XRX can be described as very cheap.
Based on the Price/Forward Earnings ratio, XRX is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of XRX to the average of the S&P500 Index (35.79), we can say XRX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.86
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XRX is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
XRX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. XRX is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.2
EV/EBITDA 17.36
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

XRX's earnings are expected to grow with 14.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.66%
EPS Next 3Y14.6%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.13%, XRX has a reasonable but not impressive dividend return.
In the last 3 months the price of XRX has falen by -31.41%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 2.12, XRX pays a better dividend. On top of this XRX pays more dividend than 94.29% of the companies listed in the same industry.
XRX's Dividend Yield is a higher than the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.13%

5.2 History

The dividend of XRX has a limited annual growth rate of 0.72%.
XRX has paid a dividend for at least 10 years, which is a reliable track record.
XRX has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.72%
Div Incr Years0
Div Non Decr Years6
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of XRX are negative and hence is the payout ratio. XRX will probably not be able to sustain this dividend level.
The dividend of XRX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-9.99%
EPS Next 2Y22.66%
EPS Next 3Y14.6%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

XEROX HOLDINGS CORP

NASDAQ:XRX (11/26/2025, 11:58:44 AM)

2.69

-0.04 (-1.47%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)01-26 2026-01-26/amc
Inst Owners99.89%
Inst Owner Change-13.25%
Ins Owners7.73%
Ins Owner Change0.04%
Market Cap338.48M
Revenue(TTM)6.61B
Net Income(TTM)-991.00M
Analysts47.27
Price Target7.62 (183.27%)
Short Float %20.57%
Short Ratio4.78
Dividend
Industry RankSector Rank
Dividend Yield 3.13%
Yearly Dividend1.14
Dividend Growth(5Y)0.72%
DP-9.99%
Div Incr Years0
Div Non Decr Years6
Ex-Date12-31 2025-12-31 (0.025)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-416.19%
Min EPS beat(2)-892.08%
Max EPS beat(2)59.69%
EPS beat(4)1
Avg EPS beat(4)-240.68%
Min EPS beat(4)-892.08%
Max EPS beat(4)59.69%
EPS beat(8)1
Avg EPS beat(8)-143.49%
EPS beat(12)5
Avg EPS beat(12)-67.93%
EPS beat(16)7
Avg EPS beat(16)-62.02%
Revenue beat(2)1
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-4.62%
Max Revenue beat(2)0.96%
Revenue beat(4)2
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)1.64%
Revenue beat(8)2
Avg Revenue beat(8)-2.56%
Revenue beat(12)3
Avg Revenue beat(12)-2.15%
Revenue beat(16)4
Avg Revenue beat(16)-1.97%
PT rev (1m)-4.27%
PT rev (3m)-10.04%
EPS NQ rev (1m)6.7%
EPS NQ rev (3m)2.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-58.51%
Revenue NQ rev (1m)-1.77%
Revenue NQ rev (3m)11.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.86
P/S 0.05
P/FCF 1.2
P/OCF 0.92
P/B 0.58
P/tB N/A
EV/EBITDA 17.36
EPS(TTM)-0.14
EYN/A
EPS(NY)1.44
Fwd EY53.69%
FCF(TTM)2.25
FCFY83.61%
OCF(TTM)2.92
OCFY108.42%
SpS52.51
BVpS4.6
TBVpS-20.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.84%
ROE -171.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.61%
FCFM 4.28%
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.38%
ROCE(5y)3.56%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 7
Debt/FCF 15.57
Debt/EBITDA 16.47
Cap/Depr 26.17%
Cap/Sales 1.27%
Interest Coverage N/A
Cash Conversion 149.19%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.77
Altman-Z 1.05
F-Score4
WACC5.6%
ROIC/WACCN/A
Cap/Depr(3y)17.3%
Cap/Depr(5y)18.56%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.59%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-20%
EPS Next Y-77.7%
EPS Next 2Y22.66%
EPS Next 3Y14.6%
EPS Next 5YN/A
Revenue 1Y (TTM)3.67%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%28.34%
Revenue Next Year12.74%
Revenue Next 2Y10.51%
Revenue Next 3Y6.25%
Revenue Next 5Y-0.46%
EBIT growth 1Y-135.71%
EBIT growth 3Y-23.42%
EBIT growth 5Y-32.65%
EBIT Next Year77.35%
EBIT Next 3Y38.67%
EBIT Next 5Y20.31%
FCF growth 1Y-35.39%
FCF growth 3Y-5.93%
FCF growth 5Y-18.11%
OCF growth 1Y-24.02%
OCF growth 3Y-6.69%
OCF growth 5Y-17.45%

XEROX HOLDINGS CORP / XRX FAQ

What is the ChartMill fundamental rating of XEROX HOLDINGS CORP (XRX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to XRX.


What is the valuation status for XRX stock?

ChartMill assigns a valuation rating of 5 / 10 to XEROX HOLDINGS CORP (XRX). This can be considered as Fairly Valued.


What is the profitability of XRX stock?

XEROX HOLDINGS CORP (XRX) has a profitability rating of 2 / 10.


Can you provide the financial health for XRX stock?

The financial health rating of XEROX HOLDINGS CORP (XRX) is 2 / 10.


Can you provide the dividend sustainability for XRX stock?

The dividend rating of XEROX HOLDINGS CORP (XRX) is 6 / 10 and the dividend payout ratio is -9.99%.